In: Vaccines, 2021, vol. 9, no. 9, p. 7
Since marketing authorization, cases of neuralgic amyotrophy (NA), facial paralysis/Bell’s palsy (FP/BP), and Guillain-Barré syndrome (GBS) were reported with COVID-19 vaccines of different technologies. This study aimed to assess whether NA, FP/BP, and GBS were more frequently reported in VigiBase with COVID-19 vaccines (of any technologies) than with other viral vaccines, over the full...
|
In: International Archives of Occupational and Environmental Health, 2015, vol. 88, no. 6, p. 697-705
|
In: European Radiology, 2015, vol. 25, no. 9, p. 2745-2753
|
In: Social Indicators Research, 2015, vol. 122, no. 1, p. 189-210
|
In: Plasma Chemistry and Plasma Processing, 2010, vol. 30, no. 6, p. 779-793
|
In: European Spine Journal, 2013, vol. 22, p. 466-470
|
In: Intensive Care Medicine, 2004, vol. 30, no. 7, p. 1292-1297
|
In: Annals of Hematology, 2003, vol. 82, no. 9, p. 570-573
|
In: Archives of Orthopaedic and Trauma Surgery, 2008, vol. 128, no. 6, p. 621-625
|
In: Intensive Care Medicine, 2004, vol. 30, no. 6, p. 1041-1046
|